Skip to main content
SpringerLink
Log in

Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease

  • Minireview
  • Published:
Molecular Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

  1. Gilbert SF. (1997) Developmental Biology, 4th ed. Sunderland, MA: Sinauer Associates.

    Google Scholar 

  2. D’Amore PA, Thompson RW. (1987) Mechanisms of angiogenesis. Annu. Rev. Physiol. 49: 453–464.

    Article  PubMed  Google Scholar 

  3. Folkman J. (1971) Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med. 285: 1182–1186.

    Article  CAS  PubMed  Google Scholar 

  4. Takeshita S, Zheng LP, Brogi E, et al. (1994) Therapeutic angiogenesis: A single intra-arterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hindlimb model. J. Clin. Invest. 93: 662–670.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. (1992) Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor. J. Vasc. Surg. 16: 181–191.

    Article  CAS  PubMed  Google Scholar 

  6. Pu LQ, Sniderman AD, Brassard R, et al. (1993) Enhanced revascularization of the ischemic limb by means of angiogenic therapy. Circulation 88: 208–215.

    Article  CAS  PubMed  Google Scholar 

  7. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. (1992) Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 257: 1401–1403.

    Article  CAS  PubMed  Google Scholar 

  8. Levy AP, Tamargo R, Brem H, Nathans D. (1989) An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 2: 9–19.

    Article  CAS  PubMed  Google Scholar 

  9. Connolly DT, Hewelman DM, Nelson R, et al. (1989) Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84: 1470–1478.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Ferrara N, Henzel WJ. (1989) Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun. 161: 851–855.

    Article  CAS  PubMed  Google Scholar 

  11. Pu LQ, Jackson S, Lachapelle KJ, et al. (1994) A persistent hindlimb ischemia model in the rabbit. J. Invest. Surg. 7: 49–60.

    Article  CAS  PubMed  Google Scholar 

  12. Takeshita S, Pu L-Q, Zheng L, et al. (1994) Vascular endothelial growth factor induces dose-dependent revascularization in a rabbit model of persistent limb ischemia. Circulation 90: II–228–II–234.

    Google Scholar 

  13. Bauters C, Asahara T, Zheng LP, et al. (1994) Physiologic assessment of augmented vascularity induced by VEGF in ischemic rabbit hindlimb. Am. J. Physiol. 267: H1263–H1271.

    PubMed  CAS  Google Scholar 

  14. Banai S, Jaklitsch MT, Shou M, et al. (1994) Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89: 2183–2189.

    Article  CAS  PubMed  Google Scholar 

  15. Unger EF, Banai S, Shou M, et al. (1994) Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am. J. Physiol. 266: H1588–H1595.

    PubMed  CAS  Google Scholar 

  16. Hariawala M, Horowitz JR, Esakof D, et al. (1996) VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts. J. Surg. Res. 63: 77–82.

    Article  CAS  PubMed  Google Scholar 

  17. Pearlman JD, Hibberd MG, Chuang ML, et al. (1995) Magnetic resonance mapping demonstrates benefits of VEGF-induced myocardial angiogenesis. Nature Med. 1: 1085–1089.

    Article  CAS  PubMed  Google Scholar 

  18. Selke FW, Jianyi L, Stamler A, Lopez JJ, Thomas KA, Simons M. (1996) Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemia. Surgery 120: 182–188.

    Article  Google Scholar 

  19. Sellke FW, Wang SY, Friedman M, et al. (1994) Basic FGF enhances endothelium-dependent relaxation of the collateral-perfused coronary microcirculation. Am. J. Physiol. 267: H1303–H1311.

    PubMed  CAS  Google Scholar 

  20. Harada K, Grossman W, Friedman M, et al. (1994) Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest. 94: 623–630.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Asahara T, Bauters C, Zheng LP, et al. (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92: II–365–II–371.

    Article  Google Scholar 

  22. Bauters C, Asahara T, Zheng LP, et al. (1995) Site-specific therapeutic angiogenesis following systemic administration of vascular endothelial growth factor. J. Vasc. Surg. 21: 314–325.

    Article  CAS  PubMed  Google Scholar 

  23. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM. (1998) Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor. Circulation 97: 381–390.

    Article  PubMed  Google Scholar 

  24. Yang HT, Deschenes MR, Ogilvie RW, Terjung RL. (1996) Basic fibroblast growth factor increases collateral blood flow in rats with femoral arterial ligation. Circ. Res. 79: 62–69.

    Article  CAS  PubMed  Google Scholar 

  25. Walder CE, Errett CJ, Ogez J, et al. (1996) Vascular endothelial growth factor (VEGF) improves blood flow and function in a chronic ischemic hind limb model. J. Cardiovasc. Pharmacol. 27: 91–98.

    Article  CAS  PubMed  Google Scholar 

  26. Schumacher B, Pecher P, von Specht BU, Stegmann TH. (1998) Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97: 645–650.

    Article  CAS  PubMed  Google Scholar 

  27. Tischer E, Mitchell R, Hartmann T, et al. (1991) The human gene for vascular endothelial growth factor: Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266: 11947–11954.

    PubMed  CAS  Google Scholar 

  28. Losordo DW, Pickering JG, Takeshita S, et al. (1994) Use of the rabbit ear artery to serially assess foreign protein secretion after site specific arterial gene transfer in vivo: Evidence that anatomic identification of successful gene transfer may underestimate the potential magnitude of transgene expression. Circulation 89: 785–792.

    Article  CAS  PubMed  Google Scholar 

  29. Takeshita S, Losordo DW, Kearney M, Isner JM. (1994) Time course of recombinant protein secretion following liposome-mediated gene transfer in a rabbit arterial organ culture model. Lab. Invest. 71: 387–391.

    PubMed  CAS  Google Scholar 

  30. Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. (1993) Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther. 4: 749–758.

    Article  CAS  PubMed  Google Scholar 

  31. Takeshita S, Weir L, Chen D, et al. (1996) Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia. Biochem. Biophys. Res. Commun. 227: 628–635.

    Article  CAS  PubMed  Google Scholar 

  32. Takeshita S, Tsurumi Y, Couffinhal T, et al. (1996) Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest. 75: 487–502.

    PubMed  CAS  Google Scholar 

  33. Tsurumi Y, Chen D, Silver M, et al. (1997) Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 96: II–382–II–388.

    PubMed  CAS  Google Scholar 

  34. Isner JM, Walsh K, Symes J, et al. (1996) Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther. 7: 959–988.

    Article  CAS  PubMed  Google Scholar 

  35. European Working Group on Critical Leg Ischemia. (1991) Second European consensus document on chronic critical leg ischemia. Circulation 84: IV–1–IV–26.

    Google Scholar 

  36. Dormandy J, Mahir M, Ascady G, et al. (1989) Fate of the patient with chronic leg ischaemia. J. Cardiovasc. Surg. 1: 50–57.

    Google Scholar 

  37. Rutherford RB, Flanigan DP, Gupta SK, et al. (1986) Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery/North American Chapter, International Society for Cardiovascular Surgery. J. Vasc. Surg. 4: 80–94.

    Article  Google Scholar 

  38. Isner JM, Rosenfield K. (1993) Redefining the treatment of peripheral artery disease. Circulation 88: 1534–1557.

    Article  CAS  PubMed  Google Scholar 

  39. Most RS, Sinnock P. (1983) The epidemiology of lower extremity amputations in diabetic individuals. Diabetes Care 6: 87–91.

    Article  CAS  PubMed  Google Scholar 

  40. Taylor LM Jr, Porter JM. (1995) Natural history and non-operative treatment of chronic lower extremity ischemia. In: Rutherford RB (ed). Vascular Surgery. W.B. Saunders, Philadelphia, 751–766.

    Google Scholar 

  41. Wolfe JHN. (1986) Defining the outcome of critical ischemia: A one-year prospective study. Br. J. Surg. 73: 321–328.

    Article  Google Scholar 

  42. Eneroth M, Persson BM. (1992) Amputation for occlusive arterial disease. A multicenter study of 177 amputees. Int. Orthop. 16: 382–387.

    Article  Google Scholar 

  43. Campbell WB, Johnston JA, Kernick VF, Rutter EA. (1994) Lower limb amputation: Striking the balance. Ann. R. Coll. Surg. Engl. 76: 205–209.

    PubMed  PubMed Central  CAS  Google Scholar 

  44. Dawson I, Keller BP, Brand R, Pesch-Batenburg J, Hajo van Bockel J. (1995) Late outcomes of limb loss after failed infrainguinal bypass. J. Vasc. Surg. 21: 613–622.

    Article  CAS  PubMed  Google Scholar 

  45. Skinner JA, Cohen AT. (1996) Amputation for premature peripheral atherosclerosis: Do young patients do better? Lancet 348: 1396.

    Article  CAS  PubMed  Google Scholar 

  46. Isner JM, Pieczek A, Schainfeld R, et al. (1996) Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165. Lancet 348: 370–374.

    Article  CAS  PubMed  Google Scholar 

  47. Baumgartner I, Pieczek A, Manor O, et al. (1998) Constitutive expression of phVEGF165 following intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97: 1114–1123.

    Article  CAS  PubMed  Google Scholar 

  48. Giordano FJ, Ping P, McKirnan D, et al. (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nature Med. 2: 534–539.

    Article  CAS  PubMed  Google Scholar 

  49. Mack CA, Patel SR, Schwarz EA, et al. (1998) Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115: 168–176.

    Article  CAS  PubMed  Google Scholar 

  50. Tabata H, Silver M, Isner JM. (1997) Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: Critical role of secretion signal in use of naked DNA. Cardiovasc. Res. 35: 470–479.

    Article  CAS  PubMed  Google Scholar 

  51. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. (1991) Hypotensive activity of fibroblast growth factor. Science 254: 1208–1210.

    Article  CAS  PubMed  Google Scholar 

  52. Yang R, Bunting S, Ko A, Keyt B, Jin H. (1995) Hemodynamic effects of vascular endothelial growth factor in conscious rats [Abstract]. Circulation 92: I–659.

    Article  Google Scholar 

  53. Horowitz JR, Rivard A, van der Zee R, Hariawala M, Sheriff DD, Esakof D, Chaudhry GM, Symes JF, Isner JM. (1997) Vascular endothelial growth factor/vascular permeability factor produces nitric oxide-dependent hypotension. Arterioscler. Thromb. Vasc. Biol. 17: 2793–2800.

    Article  CAS  PubMed  Google Scholar 

  54. Yang R, Bunting S, Ko A, et al. (1997) Substantially attenuated hemodynamic responses to Escherichia coli-derived vascular endothelial growth factor given by intravenous infusion compared with bolus injection. J. Pharmacol. Exp. Ther. 284: 103–110.

    Google Scholar 

  55. Graham AM, Baffour R, Burdon T, et al. (1989) A demonstration of vascular proliferation in response to arteriovenous reversal in the ischemic canine hind limb. J. Surg. Res. 47: 341–347.

    Article  CAS  PubMed  Google Scholar 

  56. Symes JF, Graham AM, Stein L, Sniderman AD. (1984) Salvage of a severely ischemic limb by arteriovenous revascularization: A case report. Can. J. Surg. 27: 274–276.

    PubMed  CAS  Google Scholar 

  57. Longland CJ. (1953) The collateral circulation of the limb. Ann. R. Coll. Surg. Engl. 13: 161–181.

    PubMed  PubMed Central  CAS  Google Scholar 

  58. Takeshita S, Rossow ST, Kearney M, et al. (1995) Time course of increased cellular proliferation in collateral arteries following administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiency. Am. J. Pathol. 147: 1649–1660.

    PubMed  PubMed Central  CAS  Google Scholar 

  59. Conn G, Soderman D, Schaeffer M-T, Wile M, Hatcher VB, Thomas KA. (1990) Purification of glycoprotein vascular endothelial cell mitogen from a rat glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 87: 1323–1327.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Schaper W, Brahander MD, Lewi P. (1971) DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ. Res. 28: 671–679.

    Article  CAS  PubMed  Google Scholar 

  61. Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B. (1982) DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am. J. Physiol. 242: H1031–H1037.

    PubMed  CAS  Google Scholar 

  62. Bucay M, Nguy JH, Barrios R, Kerns SA, Henry PD. (1992) Impaired macro- and microvascular growth in hypercholesterolemic rabbits [Abstract]. J. Am. Coll. Cardiol. 19: 151A.

    Google Scholar 

  63. Clauss M, Gerlach M, Gerlach H, et al. (1990) Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172: 1535–1545.

    Article  CAS  PubMed  Google Scholar 

  64. Shen H, Clauss M, Ryan J, et al. (1993) Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81: 2767–2773.

    PubMed  CAS  Google Scholar 

  65. Herbert JM, Lamarche I, Prabonnaud V, Dol F, Gauthier T. (1994) Tissue-type plasminogen activator is a potent mitogen for human aortic smooth muscle cells. J. Biol. Chem. 269: 3076–3080.

    PubMed  CAS  Google Scholar 

  66. Pepper MS, Ferrara N, Orci L, Montesano R. (1991) Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem. Biophys. Res. Commun. 181: 902–906.

    Article  CAS  PubMed  Google Scholar 

  67. Ross R, Glomset B, Kariya B, Harker L. (1974) A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc. Natl. Acad. Sci. U.S.A. 71: 1207–1210.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  68. Collins T, Ginsburg D, Boss JM, Orkin SH, Pober JS. (1985) Cultured human endothelial cells express platelet-derived growth factor B chain: cDNA cloning and structural analysis. Nature 316: 748–750.

    Article  CAS  PubMed  Google Scholar 

  69. Collins T, Pober JS, Gimbrone MA Jr, Betsholtz C, Westermark B, Heldin C-H. (1987) Cultured human endothelial cells express platelet-derived factor A chain. Am. J. Pathol. 126: 7–12.

    PubMed  PubMed Central  CAS  Google Scholar 

  70. Bowen-Pope DF, Hart CE, Weifert RA. (1989) Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptors. J. Biol. Chem. 264: 2502–2508.

    PubMed  CAS  Google Scholar 

  71. Zerwes H-G, Risau W. (1987) Polarized secretion of a platelet-derived growth factor-like chemotactic factor by endothelial cells in vitro. J. Cell Biol. 105: 2037–2041.

    Article  CAS  PubMed  Google Scholar 

  72. Gay CG, Winkles JA. (1990) Heparin-binding growth factor-1 stimulation of human endothelial cells induces platelet-derived growth factor A-chain gene expression. J. Biol. Chem. 265: 3284–3292.

    PubMed  CAS  Google Scholar 

  73. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. (1995) Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: Synergistic interaction with hypoxia. Circulation 92: 11–14.

    Article  CAS  PubMed  Google Scholar 

  74. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. (1991) Role of basic fibroblast growth factor in vascular lesion formation. Circ. Res. 68: 106–113.

    Article  CAS  PubMed  Google Scholar 

  75. Ausprunk DH, Folkman J. (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc. Res. 14: 53–65.

    Article  CAS  PubMed  Google Scholar 

  76. Sholley MM, Ferguson GP, Seibel HR, Montour JL, Wilson JD. (1984) Mechanisms of neovascularization: Vascular sprouting can occur without proliferation of endothelial cells. Lab. Invest. 51: 624–634.

    PubMed  CAS  Google Scholar 

  77. Jeltsch M, Kaipainen A, Joukov V, et al. (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276: 1423–1425.

    Article  CAS  PubMed  Google Scholar 

  78. Witzenbichler B, Asahara T, Murohara T, et al. (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. (In press).

  79. Joukov V, Pajusola K, Kaipainen A, et al. (1996) A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J. 15: 290–298.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  80. Lee J, Gray A, Yuan J, Luoh S, Avraham H, Wood WI. (1996) Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. Natl. Acad. Sci. U.S.A. 93: 1988–1992.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Witzenbichler B, Maisonpierre PC, Jones P, Yancopoulos GD, and Isner JM. (1998) Chemotactic properties of angiopoietin-1 and -2, ligands for endothelial-specific receptor tyrosine kinase Tie2. J. Biol. Chem. (In press).

  82. Asahara T, Chen D, Takahashi T, et al. (1998) The Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2 modulate VEGF-induced postnatal neovascularization. Circ. Res. (In press).

  83. Shyu K-G, Manor O, Magner M, Yancopoulos GD, Isner JM. (1998) Direct intramuscular injection of plasmid DNA encoding angiopoietin-1, but not angiopoietin-2, augments revascularization in the rabbit ischemic hindlimb. Circulation (In press).

  84. Folkman J, Shing Y. (1992) Angiogenesis. J. Biol. Chem. 267: 10931–10934.

    PubMed  CAS  Google Scholar 

  85. Risau W. (1995) Differentiation of endothelium. FASEB J. 9: 926–933.

    Article  CAS  PubMed  Google Scholar 

  86. Risau W, Sariola H, Zerwes H-G, et al. (1988) Vasculogenesis and angiogenesis in embryonic stem cell-derived embryoid bodies. Development 102: 471–478.

    PubMed  CAS  Google Scholar 

  87. Pardanaud L, Altman C, Kitos P, Dieterien-Lievre F. (1989) Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105: 473–485.

    PubMed  CAS  Google Scholar 

  88. Asahara T, Murohara T, Sullivan A, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 965–967.

    Article  Google Scholar 

  89. Wu MH-D, Shi Q, Wechezak AR, Clowes AW, Gordon IL, Sauvage LR. (1995) Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J. Vasc. Surg. 21: 862–867.

    Article  CAS  PubMed  Google Scholar 

  90. Shi Q, Wu MH, Hayashida N, Wechezak AR, Clowes AW, Sauvage LR. (1994) Proof of fallout endothelialization of impervious dacron grafts in the aorta and inferior vena cava of the dog. J. Vasc. Surg. 20: 546–556.

    Article  CAS  PubMed  Google Scholar 

  91. Civin CI, Banquerigo ML, Strauss LC, Loken MR. (1987) Antigen analysis of hematopoiesis. VI. Flow cytometric characterization of My-10-positive progenitor cells in normal human bone marrow. Exp. Hematol. 15: 10–17.

    PubMed  CAS  Google Scholar 

  92. Katz F, Tindle RW, Sutherland DR, Greaves MD. (1985) Identification of a membrane glycoprotein associated with hemopoietic progenitor cells. Leuk. Res. 9: 191–198.

    Article  CAS  PubMed  Google Scholar 

  93. Andrews RG, Singer JW, Bernstein ID. (1986) Monoclonal antibody 12-8 recognizes a 115-kd molecular present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 67: 842–845.

    PubMed  CAS  Google Scholar 

  94. Fina J, Molgard HV, Robertson D, et al. (1990) Expression of the CD34 gene in vascular endothelial cells. Blood 75: 2417–2426.

    PubMed  CAS  Google Scholar 

  95. Soligo D, Delia D, Oriani A, et al. (1991) Identification of CD34+ cells in normal and pathological bone marrow biopsies by OBEND10 monoclonal antibody. Leukemia 5: 1026–1030.

    PubMed  CAS  Google Scholar 

  96. Ito A, Nomura S, Hirota S, Suda T, Kitamura Y. (1995) Enhanced expression of CD 34 messenger RNA by developing endothelial cells of mice. Lab. Invest. 72: 532–538.

    PubMed  CAS  Google Scholar 

  97. deVries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. (1992) The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989–991.

    Article  CAS  Google Scholar 

  98. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. (1991) Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6: 1677–1683.

    PubMed  CAS  Google Scholar 

  99. Shalaby F, Rossant J, Yamaguchi TP, et al. (1995) Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376: 62–66.

    Article  CAS  PubMed  Google Scholar 

  100. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl. Acad. Sci. U.S.A. 88: 9026–9030.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  101. Millauer B, Wizigmann-Voos S, Schnurch H, et al. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835–846.

    Article  CAS  PubMed  Google Scholar 

  102. Yamaguchi TP, Dumont DJ, Conlon RA, Breitman ML, Rossant J. (1993) flk-1, and flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118: 489–498.

    PubMed  CAS  Google Scholar 

  103. Senger DR, Ledbetter SR, Claffey KP, Papadopoulos-Sergiou A, Perruzzi CA, Detmar M. (1996) Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the avb3 integrin, osteopontin, and thrombin. Am. J. Pathol. 149: 293–305.

    PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine (Cardiology) and Biomedical Research, St. Elizabeth’s Medical Center, Tufts University School of Medicine, 736 Cambridge Street, Boston, Massachusetts, 02135, USA

    Alain Rivard &  Jeffrey M. Isner

Authors
  1. Alain Rivard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jeffrey M. Isner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jeffrey M. Isner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rivard, A., Isner, J.M. Angiogenesis and Vasculogenesis in Treatment of Cardiovascular Disease. Mol Med 4, 429–440 (1998). https://doi.org/10.1007/BF03401749

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03401749

Keywords

Search

Navigation